I.D. Bradbrook
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 3
- Pharmacogenetics and Drug Metabolism 2
- Pharmacological Effects of Natural Compounds 2
- Coffee research and impacts 2
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 3
- Pharmacogenetics and Drug Metabolism 2
- Pharmacological Effects of Natural Compounds 2
- Coffee research and impacts 2
-
- Analytical Methods in Pharmaceuticals 3
-
- Analytical Chemistry and Chromatography 2
-
- Drug Transport and Resistance Mechanisms 2
-
- Diabetes Treatment and Management 2
I.D. Bradbrook
15 papers receiving 310 citations
Peers
Comparison fields: 5 of 82
- Pharmacology 157
- Pharmacology 48
- Chemical Health and Safety 3
- Pharmaceutical Science 22
- Molecular Medicine 17
Countries citing papers authored by I.D. Bradbrook
This map shows the geographic impact of I.D. Bradbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.D. Bradbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.D. Bradbrook more than expected).
Fields of papers citing papers by I.D. Bradbrook
This network shows the impact of papers produced by I.D. Bradbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.D. Bradbrook. The network helps show where I.D. Bradbrook may publish in the future.
Co-authorship network
The 21 scholars most cited alongside I.D. Bradbrook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 8 | |
| 2 | 1985 | 7 | |
| 3 | 1985 | 6 | |
| 4 | 1983 | 44 | |
| 5 | 1982 | 1 | |
| 6 | A study of repeated administration of fenbufen in patients with chronic rheumatic disorders and renal impairment. | 1982 | 1 |
| 7 | 1982 | 2 | |
| 8 | 1982 | 26 | |
| 9 | 1981 | 6 | |
| 10 | 1981 | 5 | |
| 11 | 1981 | 158 | |
| 12 | 1980 | 12 | |
| 13 | 1979 | 8 | |
| 14 | 1978 | 48 | |
| 15 | 1971 | 3 |
About I.D. Bradbrook
I.D. Bradbrook is a scholar working on Pharmacology, Family Practice, Gastroenterology, Pharmacology and Analytical Chemistry, having authored 15 papers that have together received 335 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Analytical Methods in Pharmaceuticals (3 papers), Analytical Chemistry and Chromatography (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Pharmacological Effects of Natural Compounds (2 papers), Diabetes Treatment and Management (2 papers) and Coffee research and impacts (2 papers). The work is most often cited by research in Pharmacology (157 citations), Pharmacology (48 citations), Chemical Health and Safety (3 citations), Pharmaceutical Science (22 citations) and Molecular Medicine (17 citations). I.D. Bradbrook has collaborated with scholars based in United Kingdom. Frequent co-authors include H. J. Rogers, P. J. Morrison, R E Newton, Michael Lind, R. G. Spector, J.R. Trounce, Hilary J. Rogers, David Cox, Christopher James and Henry C. Rogers. Their work appears in journals such as European Journal of Clinical Pharmacology, Journal of Antimicrobial Chemotherapy, Pharmacology, British Journal of Cancer and Biopharmaceutics & Drug Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.